Tiotropium and olodaterol fixed-dose combination <i>versus</i> mono-components in COPD (GOLD 2–4)Roland Buhl, Eric Bateman, Lorcan McGarvey et al.|European Respiratory Journal|2015Cited by 322
An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary DiseaseBartolomé R. Celli, John W. Walsh, Marc Decramer et al.|American Journal of Respiratory and Critical Care Medicine|2015Cited by 217
An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBartolomé R. Celli, John W. Walsh, Marc Decramer et al.|European Respiratory Journal|2015Cited by 203
Tiotropium + olodaterol shows clinically meaningful improvements in quality of lifeDave Singh, Leif Bjermer, Gary T. Ferguson et al.|Respiratory Medicine|2015Cited by 174